Tanvex Biopharma (TANVF) Cash flow

6 Followers

Tanvex Biopharma Cash Flow

TANVF's free cash flow for Q4 2022 was $-330.99M. For the 2022 fiscal year, TANVF's free cash flow was decreased by $-12.56M and operating cash flow was $-293.26M. See a summary of the company’s cash flow.

Cash Flow	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Operating Cash Flow	$ -1.33B	$ -1.39B	$ -1.79B	$ -1.90B	$ -1.61B
Investing Cash Flow	$ ―	$ ―	$ ―	$ ―	$ ―
Financing Cash Flow	$ ―	$ ―	$ ―	$ ―	$ ―
End Cash Position	$ ―	$ ―	$ ―	$ ―	$ ―
Free Cash Flow	$ -1.43B	$ -1.42B	$ -1.86B	$ -1.99B	$ -1.71B

Currency in USD